RecruitingNCT06936449

Long-term Follow-up of a Cochlear Implant With Dexamethasone Eluting Electrode Array

Long-term Follow-up of a Cohort of Adult CI632D and CI632 Participants in the CLTD5759 CI-DEX Study


Sponsor

Cochlear

Enrollment

19 participants

Start Date

May 5, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

A long-term follow-up of Cochlear's cochlear implant electrode array which passively elutes dexamethasone for a defined period of time to help reduce inflammatory responses.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Subjects who completed study obligations of the CLTD5759 CI-DEX study and enrolled at a site selected for participation.
  • Subjects implanted with a CI632D or a CI632 cochlear implant under the CLTD5759 (NCT04750642).
  • Willing and able to provide written informed consent.

Exclusion Criteria4

  • Unrealistic expectations on the part of the subject, regarding the possible benefits, risks, and limitations that are inherent to participation as determined by the Investigator.
  • Additional disabilities that may affect the subject's participation or safety during the clinical investigation.
  • Unable or unwilling to comply with all the requirements of the clinical investigation as determined by the Investigator.
  • Currently participating, or participated within the last 30 days, in another interventional clinical investigation/trial involving an investigational drug or device.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECI632D

CI632 cochlear implant with Slim Modiolar electrode including dexamethasone in the electrode within wells

DEVICECI632

CI632 cochlear implant with Slim Modiolar electrode with market approval and does not include dexamethasone


Locations(3)

Rocky Mountain Ear Center

Englewood, Colorado, United States

University of Iowa

Iowa City, Iowa, United States

University Hospitals Cleveland

Cleveland, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06936449


Related Trials